"Multi-component-multi-target-multi-pathway" mechanism of Kuihua Hugan Tablets based on network pharmacology.
10.19540/j.cnki.cjcmm.20181214.003
- Author:
Hong-Bo SHEN
1
;
Yi-Nong ZHOU
1
;
Jie ZHENG
1
;
Ruo-Hai ZHU
1
Author Information
1. Deparment of Hepatobiliary Surgery, Quzhou People's Hospital Quzhou 324000, China.
- Publication Type:Journal Article
- Keywords:
Kuihua Hugan Tablets;
PharmMapper;
chronic hepatitis and early cirrhosis;
molecular docking;
network pharmacology
- MeSH:
Drugs, Chinese Herbal;
pharmacology;
Medicine, Chinese Traditional;
Metabolic Networks and Pathways;
Molecular Docking Simulation;
Protein Interaction Mapping;
Tablets
- From:
China Journal of Chinese Materia Medica
2019;44(7):1464-1474
- CountryChina
- Language:Chinese
-
Abstract:
To predict the targets of active ingredients of Kuihua Hugan Tablets by network pharmacology, and explore the "multi-component-multi-target-multi-pathway" hepatoprotective mechanism of action. First, through traditional Chinese medicine systems pharmacology(TCMSP) and TCM Database@Taiwan Database, main active ingredients of Kuihua Hugan Tablets were screened out based on oral bioavailability(OB), drug-likeness(DL) and effective half-lives(HL). The targets of active ingredients of Kuihua Hugan Tablets were predicted based on the PharmMapper method. Then, the prediction was conducted by screening the target genes associated with chronic hepatitis and early cirrhosis through CooLGeN and GeneCards databases. Target gene functions and signal pathways were analyzed by bioinformatics annotation database Metascape. Cytoscape software was used to construct the Kuihua Hugan Tablets ingredient-target and ingredient-target-pathway network. String database combined with Cytoscape software was used to construct the networks of component-target and component-target-pathway. STRING database was combined with Cytoscape software to draw protein-protein interaction(PPI) network and conduct network topology analysis. Finally, Systems Dock Web Site software was applied in verifying the molecular docking between active ingredients and potential protein targets. A total of 26 compounds and 509 potential targets were screened out from Kuihua Hugan Tablets in the experiment. The results of PPI network analysis indicated that albumin(ALB), insulin-like growth factor 1(IGF1), matrix metalloproteinase-9(MMP9), matrix metalloproteinase-2(MMP2), non-receptor tyrosine kinase proto-oncogene(SRC), estrogen receptor 1(ESR1) and cancer-signal transduction-inflammation-drugs metabolism-related biological processes and metabolic pathways were closely associated with the active ingredients in Kuihua Hugan Tablets. The effects of Kuihua Hugan Tablets in alleviating chronic hepatitis and early cirrhosis indicated the multi-component, multi-target, and multi-pathway characteristics of traditional Chinese medicines, providing new ideas for further research and development of Kuihua Hugan Tablets.
